Copyright
©The Author(s) 2015.
World J Dermatol. Feb 2, 2015; 4(1): 50-56
Published online Feb 2, 2015. doi: 10.5314/wjd.v4.i1.50
Published online Feb 2, 2015. doi: 10.5314/wjd.v4.i1.50
Table 2 International Society for Cutaneous Lymphomas and European organization of Research and treatment of cancer TNM classification staging for cutaneous lymphomas other than mycosis fungoides and Sezary syndrome
T |
T1: Solitary skin involvement |
T1a: A solitary lesion less than 5 cm diameter |
T1b: A solitary lesion greater than 5 cm diameter |
T2: Regional skin involvement |
T2a: All disease in a 15-cm-diameter circular area |
T2b: All disease in a 15 and 30 cm diameter circular area |
T2c: All disease in a 30-cm-diameter circular area |
T3: Generalized skin involvement |
T3a: Multiple lesions involving 2 noncontiguous body regions |
T3b: Multiple lesions involving 3 or more body regions |
N |
N1: Involvement of 1 peripheral lymph node region that drains an area of current or prior skin involvement |
N2: Involvement of 2 or more peripheral lymph node regions or involvement of any lymph node region that does not drain an area of current or prior skin involvement |
N3: Involvement of central lymph nodes |
M |
M0: No evidence of extra-cutaneous disease (other than lymph node) |
M1: Extracutaneous disease is present (other than lymph node) |
- Citation: Yilmaz F, Soyer N, Vural F. Primary cutaneous B cell lymphoma: Clinical features, diagnosis and treatment. World J Dermatol 2015; 4(1): 50-56
- URL: https://www.wjgnet.com/2218-6190/full/v4/i1/50.htm
- DOI: https://dx.doi.org/10.5314/wjd.v4.i1.50